Business Context and Reporting Period
This Form 6-K filing by Ambev S.A. reports a material fact regarding a new share buyback program approved by the Board of Directors on May 15 and 16, 2024. The filing was submitted in May 2024, with the program effective until November 16, 2025.
Key Financial Metrics
The filing does not provide specific revenue, profit, cash flow, margin, or debt figures for the period. The only quantitative financial data disclosed relates to capital structure and the buyback authorization:
- Outstanding Shares: 4,410,858,485 common shares (as defined in CVM Resolution 77/2022).
- Buyback Limit: Up to 24,000,000 common shares.
- Funding Source: Deduction from the capital reserve account recorded in the balance sheet dated March 31, 2024.
Material Changes
The primary material change is the initiation of a new share repurchase program following the conclusion of the previous program approved in May 2023, which reached its repurchase limit. The new program authorizes the repurchase of up to 24 million shares, representing approximately 0.54% of the outstanding share count.
Guidance, Outlook, and Management Commentary
Management has not provided financial guidance or operational outlook in this specific filing. The stated purpose of the buyback program is to cover share delivery requirements for share-based compensation plans or to hold shares in treasury for cancellation or subsequent transfer. The transactions will be executed through UBS Brasil and Merrill Lynch S.A.
Investor Verification Checklist
- Verify the exact number of shares repurchased under the new program via subsequent disclosures.
- Confirm the impact of the buyback on the capital reserve account using the March 31, 2024, balance sheet.
- Monitor the execution timeline to ensure compliance with the November 16, 2025, expiration date.
- Review the Company's website and B3 S.A. for the detailed "Notice Regarding the Negotiation of Shares Issued by the Company."